EPISODE · May 10, 2023 · 36 MIN
Meeting the challenge of Antimicrobial Resistance (AMR)
from Breakthroughs · host Pfizer
Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society. PP-UNP-GBR-11741 / March 2025 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society. PP-UNP-GBR-11741 / March 2025
NOW PLAYING
Meeting the challenge of Antimicrobial Resistance (AMR)
No transcript for this episode yet
Similar Episodes
Jun 22, 2026 ·2m
Jun 18, 2026 ·3m